First Heartland Consultants, Inc. Eli Lilly & CO Transaction History

First Heartland Consultants, Inc.

$930 Million
Q3 2024

A detailed history of First Heartland Consultants, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, First Heartland Consultants, Inc. holds 3,931 shares of LLY stock, worth $3.12 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

3,931

Previous 4,165 5.62%

Holding current value

$3.12 Million

Previous $3.77 Million 7.66%

% of portfolio

0.37%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$772.14 - $960.02 $180,680 - $224,644	-234 Reduced 5.62%	3,931 $3.48 Million
Q2 2024 Jul 25, 2024	SELL	$724.87 - $909.04 $21,021 - $26,362	-29 Reduced 0.69%	4,165 $3.77 Million
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $104,819 - $140,233	177 Added 4.41%	4,194 $3.26 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $35,187 - $41,481	67 Added 1.7%	4,017 $2.34 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $25,647 - $35,358	59 Added 1.52%	3,950 $2.12 Million
Q2 2023 Jul 26, 2023	BUY	$350.74 - $468.98 $25,954 - $34,704	74 Added 1.94%	3,891 $1.82 Million
Q1 2023 Apr 17, 2023	SELL	$310.63 - $364.82 $19,569 - $22,983	-63 Reduced 1.62%	3,817 $1.31 Million
Q4 2022 Jan 13, 2023	BUY	$321.55 - $374.67 $50,483 - $58,823	157 Added 4.22%	3,880 $0
Q3 2022 Oct 20, 2022	SELL	$296.48 - $337.87 $86,572 - $98,658	-292 Reduced 7.27%	3,723 $1.2 Million
Q2 2022 Jul 12, 2022	SELL	$278.73 - $327.27 $13,936 - $16,363	-50 Reduced 1.23%	4,015 $1.3 Million
Q1 2022 Apr 21, 2022	SELL	$234.69 - $291.66 $48,580 - $60,373	-207 Reduced 4.85%	4,065 $1.16 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $9,668 - $11,998	-43 Reduced 1.0%	4,272 $1.18 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $115,675 - $142,354	-522 Reduced 10.79%	4,315 $997,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $7,402 - $9,575	41 Added 0.85%	4,837 $1.11 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $89,718 - $116,145	-546 Reduced 10.22%	4,796 $896,000
Q4 2020 Jan 29, 2021	BUY	$130.46 - $172.63 $17,090 - $22,614	131 Added 2.51%	5,342 $902,000
Q3 2020 Oct 21, 2020	SELL	$146.22 - $169.13 $45,474 - $52,599	-311 Reduced 5.63%	5,211 $771,000
Q2 2020 Jul 16, 2020	BUY	$136.42 - $164.18 $20,599 - $24,791	151 Added 2.81%	5,522 $907,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $62,977 - $77,948	-529 Reduced 8.97%	5,371 $745,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $8,446 - $10,461	-79 Reduced 1.32%	5,900 $775,000
Q3 2019 Nov 18, 2019	SELL	$106.79 - $116.16 $20,396 - $22,186	-191 Reduced 3.1%	5,979 $669,000
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $52,514 - $61,297	474 Added 8.32%	6,170 $684,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $236,422 - $278,286	2,124 Added 59.46%	5,696 $739,000
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $140,105 - $156,960	-1,323 Reduced 27.03%	3,572 $413,000
Q3 2018 Nov 16, 2018	SELL	$85.86 - $107.31 $16,399 - $20,496	-191 Reduced 3.76%	4,895 $525,000
Q2 2018 Aug 09, 2018	SELL	$75.7 - $86.88 $18,697 - $21,459	-247 Reduced 4.63%	5,086 $434,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $19,814 - $23,389	-267 Reduced 4.77%	5,333 $413,000
Q4 2017 Feb 26, 2018	SELL	$81.94 - $87.89 $63,749 - $68,378	-778 Reduced 12.2%	5,600 $473,000
Q3 2017 Nov 15, 2017	BUY	$77.07 - $85.54 $491,552 - $545,574	6,378	6,378 $546,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Heartland Consultants, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Heartland Consultants, Inc. with notifications on news.

Account

First Heartland Consultants, Inc. Eli Lilly & CO Transaction History